Hey, is it any surprise campus security are afraid of Command Line Interface Terrorism?
For a second I thought you were making a joke about security being afraid of the CLIT..
The challenge here is to develop a vaccine that causes the body to produce antibodies that it would NOT produce in response to an infection. This vaccine must cause the body to produce antibodies that are more general than those it would produce for any specific flu, but still specific enough that they won't attack anything beneficial.
The "vaccine" from the article is not actually a vaccine. It is a medication. A vaccine acts as you described, causing the body to produce antibodies to pathogens. However, what the article describes is actually an antibody produced outside the body, and when administered should not typically invoke an immune response. There are already many drugs like this on the market.
These drugs often have severe side effects are are not first-line therapy so the clinical use of this (in the extremely unlikely event that it makes it through clinical trials and is approved) will be very small, possibly reserved for the immunocompromised (AIDS patients, bone-marrow transplant patiets etc).
[I'm in pharmacy school.]
Google's Rebecca Ward, Senior Product Counsel for Google Chrome, now tells Ars Technica that the company tries to reuse these licenses as much as possible, "in order to keep things simple for our users." Ward admits that sometimes "this means that the legal terms for a specific product may include terms that don't apply well to the use of that product" and says that Google is "working quickly to remove language from Section 11 of the current Google Chrome terms of service. This change will apply retroactively to all users who have downloaded Google Chrome."
It looks like Google's new Chrome EULA will turn out not so evil after all.
The biggest difference between time and space is that you can't reuse time. -- Merrick Furst